Past HBV Viral Load as Predictor of Mortality and Morbidity from HCC and Chronic Liver Disease in a Prospective Study
- 1 August 2006
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 101 (8) , 1797-1803
- https://doi.org/10.1111/j.1572-0241.2006.00647.x
Abstract
In a prospective cohort study with 11 yr of follow-up, we assessed the relationship between past hepatitis B virus (HBV) viral load and mortality. Surviving cohort members were evaluated for current liver disease. We measured HBV viral load by real-time polymerase chain reaction on stored samples from cohort entry (1992-1993) in 2,763 hepatitis B surface antigen (HBsAg)-positive adults. Major end points were death from hepatocellular carcinoma (HCC) or chronic liver disease (CLD). There were 447 deaths. In the 1,683 survivors, we assessed severity of liver disease on a return visit in 2003. Viral load was divided into three categories: undetected ( or =10(5) copies/mL). For HCC, there was a significant increase in mortality across viral load categories (p(trend) < 0.001). Compared to the HBV undetected category, the relative risk (RR) for HCC mortality in the low viral load group was 1.7 (95% confidence interval [CI] 0.5-5.7) and 11.2 (3.6-35.0) in the high viral load group. For CLD mortality, the RRs were 1.5 (0.2-12.1) and 15.2 (2.1-109.8), respectively (p(trend) < 0.001). The RR associated with high viral load did not change with increased follow-up time. In surviving cohort members evaluated for liver disease in 2003, there was also a significant association of viral load with disease severity. In this prospective study, viral load is associated with increased mortality from HCC and CLD in HBV-infected subjects. Viral load may be a useful prognostic tool in HBV infection, and interventions aimed at its reduction should be explored.Keywords
This publication has 26 references indexed in Scilit:
- Predicting survival in hepatitis BGut, 2005
- The Maze of Treatments for Hepatitis BNew England Journal of Medicine, 2005
- Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in MenJNCI Journal of the National Cancer Institute, 2005
- Global Epidemiology of Hepatitis B VirusJournal of Clinical Gastroenterology, 2004
- Serum Hbv Dna As A Marker of Efficacy During Therapy for Chronic Hbv Infection: Analysis and Review of the LiteratureHepatology, 2003
- Hepatitis B e Antigen and the Risk of Hepatocellular CarcinomaNew England Journal of Medicine, 2002
- Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B VirusAnnals of Internal Medicine, 2001
- Hepatitis B virus.The major etiology of hepatocellular carcinomaCancer, 1988
- Chronic type B hepatitis and the “healthy” Hbsag carrier stateHepatology, 1987
- Clinical, Virologic and Histologic Outcome Following Seroconversion From Hbeag to Anti–Hbe in Chronic Hepatitis Type BHepatology, 1986